CIBC Private Wealth Group LLC bought a new stake in shares of Catasys, Inc. (NASDAQ:CATS) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 15,300 shares of the company’s stock, valued at approximately $187,000.
Other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in shares of Catasys by 53.8% in the 3rd quarter. Vanguard Group Inc. now owns 171,813 shares of the company’s stock valued at $2,208,000 after purchasing an additional 60,090 shares during the last quarter. Vanguard Group Inc lifted its stake in shares of Catasys by 53.8% in the 3rd quarter. Vanguard Group Inc now owns 171,813 shares of the company’s stock valued at $2,208,000 after purchasing an additional 60,090 shares during the last quarter. Janney Montgomery Scott LLC lifted its stake in shares of Catasys by 9.7% in the 4th quarter. Janney Montgomery Scott LLC now owns 143,756 shares of the company’s stock valued at $1,347,000 after purchasing an additional 12,742 shares during the last quarter. Northern Trust Corp lifted its stake in shares of Catasys by 95.2% during the 4th quarter. Northern Trust Corp now owns 19,634 shares of the company’s stock worth $184,000 after acquiring an additional 9,578 shares during the last quarter. Finally, Geode Capital Management LLC lifted its stake in shares of Catasys by 27.2% during the 4th quarter. Geode Capital Management LLC now owns 28,315 shares of the company’s stock worth $265,000 after acquiring an additional 6,050 shares during the last quarter. 12.66% of the stock is owned by institutional investors and hedge funds.
In other news, major shareholder David E. Smith sold 43,037 shares of Catasys stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $13.86, for a total value of $596,492.82. The sale was disclosed in a filing with the SEC, which is available through this link. Also, major shareholder David E. Smith sold 7,643 shares of Catasys stock in a transaction on Friday, March 22nd. The shares were sold at an average price of $13.95, for a total value of $106,619.85. The disclosure for this sale can be found here. Insiders have sold a total of 532,355 shares of company stock worth $8,298,358 over the last 90 days. 60.80% of the stock is currently owned by company insiders.
CATS opened at $17.83 on Wednesday. The firm has a market cap of $292.35 million, a price-to-earnings ratio of -20.03 and a beta of 1.76. Catasys, Inc. has a 52 week low of $6.27 and a 52 week high of $20.83.
Catasys (NASDAQ:CATS) last released its quarterly earnings data on Thursday, May 9th. The company reported ($0.18) EPS for the quarter, topping the consensus estimate of ($0.24) by $0.06. The firm had revenue of $6.81 million for the quarter, compared to analysts’ expectations of $5.64 million. As a group, equities analysts predict that Catasys, Inc. will post -0.96 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This piece was originally published by Dakota Financial News and is owned by of Dakota Financial News. If you are viewing this piece on another website, it was stolen and republished in violation of United States and international trademark and copyright law. The legal version of this piece can be accessed at https://dakotafinancialnews.com/2019/06/12/cibc-private-wealth-group-llc-buys-new-holdings-in-catasys-inc-nasdaqcats.html.
Catasys, Inc provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services.
Further Reading: How does equity income fit into an investing strategy?
Want to see what other hedge funds are holding CATS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Catasys, Inc. (NASDAQ:CATS).
Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.